Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
Conditions: Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus InfectionInterventions: Biological: Comparator: GARDASIL; Biological: Experimental: V503Sponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2007 Category: Research Source Type: clinical trials
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Conditions: Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus InfectionInterventions: Biological: Comparator: V505 formulation 1; Drug: Comparator: V505 formulation 2; Drug: Comparator: V505 formulation 2; Biological: Comparator: V505 formulation 3; Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant; Biological: Comparator: Placebo (unspecified)Sponsor: Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2007 Category: Research Source Type: clinical trials
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2); Ovarian Cancer; Sarcoma; Uterine Leiomyomata; Vaginal Cancer; Vulvar CancerInterventions: Other: laboratory biomarker analysis; Other: screening questionnaire administration; Procedure: study of high risk factorsSponsors: Northwestern University; National Cancer Institute (NCI)Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2000 Category: Research Source Type: clinical trials
